{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:49:29Z","timestamp":1792273769112,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12010-023-04520-y","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T06:02:03Z","timestamp":1683957723000},"page":"717-728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["LCN2 Promotes Proliferation and Glycolysis by Activating the JAK2\/STAT3 Signaling Pathway in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"196","author":[{"given":"Baojun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"issue":"9","key":"4520_CR1","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/liv.15130","volume":"42","author":"T Torimura","year":"2021","unstructured":"Torimura, T., & Iwamoto, H. (2021). Treatment and the prognosis of hepatocellular carcinoma in Asia. Liver International, 42(9), 2042.","journal-title":"Liver International"},{"issue":"5","key":"4520_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jb\/mvab088","volume":"170","author":"T Sun","year":"2021","unstructured":"Sun, T., & Zhang, J. (2021). ETV4 mediates the Wnt\/\u03b2-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. Journal of biochemistry, 170(5), 663\u2013673.","journal-title":"Journal of biochemistry"},{"key":"4520_CR3","doi-asserted-by":"publisher","first-page":"104454","DOI":"10.1016\/j.phrs.2019.104454","volume":"150","author":"R Wu","year":"2019","unstructured":"Wu, R., et al. (2019). Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis. Pharmacological Research, 150, 104454.","journal-title":"Pharmacological Research"},{"issue":"6","key":"4520_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/10409238.2018.1556578","volume":"53","author":"S Ganapathy-Kanniappan","year":"2018","unstructured":"Ganapathy-Kanniappan, S. (2018). Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype. Critical Reviews In Biochemistry And Molecular Biology, 53(6), 667\u2013682.","journal-title":"Critical Reviews In Biochemistry And Molecular Biology"},{"issue":"3","key":"4520_CR5","doi-asserted-by":"publisher","first-page":"e12603","DOI":"10.1111\/cpr.12603","volume":"52","author":"Y Qin","year":"2019","unstructured":"Qin, Y., et al. (2019). Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK\/cMyc axis in pancreatic cancer. Cell Proliferation, 52(3), e12603.","journal-title":"Cell Proliferation"},{"issue":"40","key":"4520_CR6","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1074\/jbc.RA119.007508","volume":"294","author":"Y Li","year":"2019","unstructured":"Li, Y., et al. (2019). The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation. The Journal Of Biological Chemistry, 294(40), 14745\u201314756.","journal-title":"The Journal Of Biological Chemistry"},{"issue":"8","key":"4520_CR7","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1111\/cas.15370","volume":"113","author":"W Wang","year":"2022","unstructured":"Wang, W., et al. (2022). LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple-negative breast cancer. Cancer Science, 113(8), 2484.","journal-title":"Cancer Science"},{"issue":"2","key":"4520_CR8","first-page":"551","volume":"53","author":"X Li","year":"2018","unstructured":"Li, X., et al. (2018). lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPAR\u03b3 pathway in hepatocellular carcinoma. International Journal Of Oncology, 53(2), 551\u2013566.","journal-title":"International Journal Of Oncology"},{"issue":"11","key":"4520_CR9","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/jcp.25755","volume":"232","author":"D Costa","year":"2017","unstructured":"Costa, D., et al. (2017). LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment. Journal Of Cellular Physiology, 232(11), 3077\u20133087.","journal-title":"Journal Of Cellular Physiology"},{"issue":"8","key":"4520_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/cns.13653","volume":"27","author":"D Lim","year":"2021","unstructured":"Lim, D., Jeong, J., & Song, J. (2021). Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature. CNS Neuroscience & Therapeutics, 27(8), 883\u2013894.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"4520_CR11","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","volume":"12","author":"F Yao","year":"2021","unstructured":"Yao, F., et al. (2021). A targetable LIFR-NF-\u03baB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nature Communications, 12(1), 7333.","journal-title":"Nature Communications"},{"issue":"1","key":"4520_CR12","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1038\/s41467-021-25632-1","volume":"12","author":"J Gao","year":"2021","unstructured":"Gao, J., Luo, T., & Wang, J. (2021). Gene interfered-ferroptosis therapy for cancers. Nature Communications, 12(1), 5311.","journal-title":"Nature Communications"},{"issue":"9","key":"4520_CR13","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1096\/fj.201902683R","volume":"34","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Ding, F., & Zheng, G. (2020). LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer. The FASEB Journal, 34(9), 11382\u201311394.","journal-title":"The FASEB Journal"},{"issue":"4","key":"4520_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.26467","volume":"58","author":"Y Wang","year":"2013","unstructured":"Wang, Y., et al. (2013). Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)\/Lcn2\/Twist1 pathway. Hepatology (Baltimore, Md.), 58(4), 1349\u20131361.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4520_CR15","doi-asserted-by":"publisher","first-page":"103857","DOI":"10.1016\/j.ebiom.2022.103857","volume":"77","author":"X Li","year":"2022","unstructured":"Li, X., et al. (2022). Targeting long noncoding RNA-AQP4-AS1 for the treatment of retinal neurovascular dysfunction in diabetes mellitus. EBioMedicine, 77, 103857.","journal-title":"EBioMedicine"},{"key":"4520_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.canlet.2017.10.008","volume":"412","author":"J Fu","year":"2018","unstructured":"Fu, J., & Wang, H. (2018). Precision diagnosis and treatment of liver cancer in China. Cancer Letters, 412, 283\u2013288.","journal-title":"Cancer Letters"},{"issue":"2","key":"4520_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/cells11020260","volume":"11","author":"S Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der, S., Pino\u00e9-Schmidt, M., & Weiskirchen, R. (2022). Lipocalin-2 (LCN2) deficiency leads to cellular changes in highly metastatic human prostate cancer cell line PC-3. Cells, 11(2), 260.","journal-title":"Cells"},{"key":"4520_CR18","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.2147\/CMAR.S278902","volume":"12","author":"J Xu","year":"2020","unstructured":"Xu, J., et al. (2020). LCN2 Mediated by IL-17 affects the proliferation, migration, invasion and cell cycle of gastric cancer cells by targeting SLPI. Cancer Management And Research, 12, 12841\u201312849.","journal-title":"Cancer Management And Research"},{"issue":"4","key":"4520_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/CBM-190084","volume":"28","author":"I Barsoum","year":"2020","unstructured":"Barsoum, I., Elgohary, M., & Bassiony, M. (2020). Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma. Cancer Biomarkers, 28(4), 523\u2013528.","journal-title":"Cancer Biomarkers"},{"issue":"11","key":"4520_CR20","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/1878-0261.13211","volume":"16","author":"H Tseng","year":"2022","unstructured":"Tseng, H., et al. (2022). A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1\u03b1-mediated aerobic glycolysis. Molecular Oncology, 16(11), 2274\u20132294.","journal-title":"Molecular Oncology"},{"key":"4520_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ebiom.2019.02.025","volume":"41","author":"K Sun","year":"2019","unstructured":"Sun, K., et al. (2019). Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. EBioMedicine, 41, 370\u2013383.","journal-title":"EBioMedicine"},{"issue":"1","key":"4520_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3892\/or.2014.3600","volume":"33","author":"X Liu","year":"2015","unstructured":"Liu, X., et al. (2015). Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells. Oncology Reports, 33(1), 157\u2013162.","journal-title":"Oncology Reports"},{"issue":"1","key":"4520_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13046-021-02059-6","volume":"40","author":"C Liu","year":"2021","unstructured":"Liu, C., et al. (2021). Pharmacological targeting PTK6 inhibits the JAK2\/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer. Journal Of Experimental & Clinical Cancer Research : Cr, 40(1), 297.","journal-title":"Journal Of Experimental & Clinical Cancer Research : Cr"},{"key":"4520_CR24","doi-asserted-by":"publisher","first-page":"109477","DOI":"10.1016\/j.cbi.2021.109477","volume":"342","author":"X Bao","year":"2021","unstructured":"Bao, X., et al. (2021). \u03b2-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2\/STAT3\/MCL-1 and NF-\u0138B signal pathways. Chemico-Biological Interactions, 342, 109477.","journal-title":"Chemico-Biological Interactions"},{"key":"4520_CR25","doi-asserted-by":"publisher","first-page":"174832","DOI":"10.1016\/j.ejphar.2022.174832","volume":"920","author":"Q Jiang","year":"2022","unstructured":"Jiang, Q., et al. (2022). Peptide identification of hepatocyte growth-promoting factor and its function in cytoprotection and promotion of liver cell proliferation through the JAK2\/STAT3\/c-MYC pathway. European Journal Of Pharmacology, 920, 174832.","journal-title":"European Journal Of Pharmacology"},{"issue":"7","key":"4520_CR26","first-page":"7940","volume":"10","author":"R Lei","year":"2017","unstructured":"Lei, R., et al. (2017). IL-9 promotes proliferation and metastasis of hepatocellular cancer cells by activating JAK2\/STAT3 pathway. International Journal Of Clinical And Experimental Pathology, 10(7), 7940\u20137946.","journal-title":"International Journal Of Clinical And Experimental Pathology"},{"issue":"9","key":"4520_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/iub.2520","volume":"73","author":"L Li","year":"2021","unstructured":"Li, L., et al. (2021). Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2\/STAT3 signaling pathway via miR-375. IUBMB Life, 73(9), 1153\u20131165.","journal-title":"IUBMB Life"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04520-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04520-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04520-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T14:29:08Z","timestamp":1708180148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04520-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04520-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"11 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Sichuan Mianyang 404 Hospital and written consent approval was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}